Evolution of inappropriate oral iron use in heart failure patients with reduced ejection fraction

20 May 2023 (08:00 - 20:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Nicolas Chapet

University Hospital Arnaud de Villeneuve, Montpellier (France)

6 More presentations in this session

Presentation thumbnail

Dapagliflozin, between the zeal of the clinical studies and the challenges of the day-to-day practice

Doctor M. ElRefai (Basildon, GB)

Abstract Slides

Presentation thumbnail

Real-world implementation of guideline-directed treatment in advanced heart failure: single center experience

Professor H. Sisakian (Yerevan, AM)

Abstract Slides

Presentation thumbnail

Flexible vs. fixed diuretic regimen in the management of advanced chronic heart failure: study protocol for a pilot randomized control trial

Doctor A. Jiang (London, CA)

Abstract Slides

Presentation thumbnail

NTproBNP is not a good prognostic marker in patients with advanced heart failure on ambulatory levosimendan infusion program

Doctor I. Fialho (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Comparison analysis of furosemide and torasemide efficacy in 24 hours of acute heart failure initial treatment

Doctor M. Malek-Elikowska (Poznan, PL)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy 1

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources